SCHEMBL17364283

SCHEMBL17364283

O=c1cc[nH]c(-c2ncnc3[nH]cnc23)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 1/20 0.35
JAK2 O60674 11/20 0.34
JAK1 P23458 7/20 0.33
KDM4A O75164 1/20 0.33
KDM4B O94953 1/20 0.33
KDM5C P41229 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
IKBKB O14920 1/20 0.33
CHUK O15111 1/20 0.33
JAK3 P52333 4/20 0.31
MAP4K4 O95819 4/20 0.31
DAPK3 O43293 3/20 0.31
PRKD3 O94806 3/20 0.31
PAK4 O96013 3/20 0.31
CSF1R P07333 3/20 0.31
RET P07949 3/20 0.31
MET P08581 3/20 0.31
PIM1 P11309 3/20 0.31
FGFR1 P11362 3/20 0.31
PRKACA P17612 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7022512 0.79 CDK5 (0.44) JAK2JAK3MAP4K4DAPK3PRKD3
SCHEMBL7027243 0.69 JAK2 (0.33) JAK2JAK1KDM4AKDM4BKDM5C
SCHEMBL7027575 0.69 ITK (0.48) RETKDRGSK3BAURKAABL1
SCHEMBL2938674 0.68 JAK2 (0.54) JAK2JAK3MAP4K4PRKD3PAK4
SCHEMBL1900509 0.66 NEK2 (0.38) JAK2IKBKBCHUKPRKACABRD4
SCHEMBL18486378 0.65 TOP2A (0.49) LIMK1
Adenine SCHEMBL1065182 0.65 MAP4K4 (0.41) PNPMAP4K4DYRK1ALRRK2PARP1
Adenine SCHEMBL19974438 0.65 MAP4K4 (0.41) PNPMAP4K4DYRK1ALRRK2PARP1
Adenine SCHEMBL4579285 0.65 MAP4K4 (0.41) PNPMAP4K4DYRK1ALRRK2PARP1
SCHEMBL17364297 0.65 ULK1 (0.44) CDK7DYRK1ALRRK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376219-A1 Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods ZHONG MINGHONG (US) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376219-A1 Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods PNP, ATIC, NT5C3B PNP 1/4885JAK2 3681/4885JAK1 4490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.